List of Tables
Table 1. Global CD20 Monoclonal Antibodies Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global CD20 Monoclonal Antibodies Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global CD20 Monoclonal Antibodies Market Competitive Situation by Manufacturers in 2025
Table 4. Global CD20 Monoclonal Antibodies Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global CD20 Monoclonal Antibodies Sales Market Share by Manufacturers (2021–2026)
Table 6. Global CD20 Monoclonal Antibodies Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global CD20 Monoclonal Antibodies Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market CD20 Monoclonal Antibodies Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of CD20 Monoclonal Antibodies, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of CD20 Monoclonal Antibodies, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of CD20 Monoclonal Antibodies, Product Types and Applications
Table 12. Global Key Manufacturers of CD20 Monoclonal Antibodies, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CD20 Monoclonal Antibodies Companies by Tier (Tier 1, Tier 2, Tier 3), based on CD20 Monoclonal Antibodies Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CD20 Monoclonal Antibodies Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global CD20 Monoclonal Antibodies Sales by Region (K Units), 2021–2026
Table 18. Global CD20 Monoclonal Antibodies Sales Market Share by Region (2021–2026)
Table 19. Global CD20 Monoclonal Antibodies Sales by Region (K Units), 2027–2032
Table 20. Global CD20 Monoclonal Antibodies Sales Market Share by Region (2027–2032)
Table 21. Global CD20 Monoclonal Antibodies Revenue by Region (US$ Million), 2021–2026
Table 22. Global CD20 Monoclonal Antibodies Revenue Market Share by Region (2021–2026)
Table 23. Global CD20 Monoclonal Antibodies Revenue by Region (US$ Million), 2027–2032
Table 24. Global CD20 Monoclonal Antibodies Revenue Market Share by Region (2027–2032)
Table 25. North America CD20 Monoclonal Antibodies Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America CD20 Monoclonal Antibodies Sales by Country (K Units), 2021–2026
Table 27. North America CD20 Monoclonal Antibodies Sales by Country (K Units), 2027–2032
Table 28. North America CD20 Monoclonal Antibodies Revenue by Country (US$ Million), 2021–2026
Table 29. North America CD20 Monoclonal Antibodies Revenue by Country (US$ Million), 2027–2032
Table 30. Europe CD20 Monoclonal Antibodies Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe CD20 Monoclonal Antibodies Sales by Country (K Units), 2021–2026
Table 32. Europe CD20 Monoclonal Antibodies Sales by Country (K Units), 2027–2032
Table 33. Europe CD20 Monoclonal Antibodies Revenue by Country (US$ Million), 2021–2026
Table 34. Europe CD20 Monoclonal Antibodies Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific CD20 Monoclonal Antibodies Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific CD20 Monoclonal Antibodies Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific CD20 Monoclonal Antibodies Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific CD20 Monoclonal Antibodies Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific CD20 Monoclonal Antibodies Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America CD20 Monoclonal Antibodies Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America CD20 Monoclonal Antibodies Sales by Country (K Units), 2021–2026
Table 42. Latin America CD20 Monoclonal Antibodies Sales by Country (K Units), 2027–2032
Table 43. Latin America CD20 Monoclonal Antibodies Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America CD20 Monoclonal Antibodies Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa CD20 Monoclonal Antibodies Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa CD20 Monoclonal Antibodies Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa CD20 Monoclonal Antibodies Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa CD20 Monoclonal Antibodies Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa CD20 Monoclonal Antibodies Revenue by Country (US$ Million), 2027–2032
Table 50. Global CD20 Monoclonal Antibodies Sales (K Units) by Type (2021–2026)
Table 51. Global CD20 Monoclonal Antibodies Sales (K Units) by Type (2027–2032)
Table 52. Global CD20 Monoclonal Antibodies Sales Market Share by Type (2021–2026)
Table 53. Global CD20 Monoclonal Antibodies Sales Market Share by Type (2027–2032)
Table 54. Global CD20 Monoclonal Antibodies Revenue (US$ Million) by Type (2021–2026)
Table 55. Global CD20 Monoclonal Antibodies Revenue (US$ Million) by Type (2027–2032)
Table 56. Global CD20 Monoclonal Antibodies Revenue Market Share by Type (2021–2026)
Table 57. Global CD20 Monoclonal Antibodies Revenue Market Share by Type (2027–2032)
Table 58. Global CD20 Monoclonal Antibodies Price (US$/Unit) by Type (2021–2026)
Table 59. Global CD20 Monoclonal Antibodies Price (US$/Unit) by Type (2027–2032)
Table 60. Global CD20 Monoclonal Antibodies Sales (K Units) by Application (2021–2026)
Table 61. Global CD20 Monoclonal Antibodies Sales (K Units) by Application (2027–2032)
Table 62. Global CD20 Monoclonal Antibodies Sales Market Share by Application (2021–2026)
Table 63. Global CD20 Monoclonal Antibodies Sales Market Share by Application (2027–2032)
Table 64. Global CD20 Monoclonal Antibodies Revenue (US$ Million) by Application (2021–2026)
Table 65. Global CD20 Monoclonal Antibodies Revenue (US$ Million) by Application (2027–2032)
Table 66. Global CD20 Monoclonal Antibodies Revenue Market Share by Application (2021–2026)
Table 67. Global CD20 Monoclonal Antibodies Revenue Market Share by Application (2027–2032)
Table 68. Global CD20 Monoclonal Antibodies Price (US$/Unit) by Application (2021–2026)
Table 69. Global CD20 Monoclonal Antibodies Price (US$/Unit) by Application (2027–2032)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche CD20 Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Roche CD20 Monoclonal Antibodies Product
Table 74. Roche Recent Developments/Updates
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis CD20 Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Novartis CD20 Monoclonal Antibodies Product
Table 79. Novartis Recent Developments/Updates
Table 80. TG Therapeutics Company Information
Table 81. TG Therapeutics Description and Business Overview
Table 82. TG Therapeutics CD20 Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. TG Therapeutics CD20 Monoclonal Antibodies Product
Table 84. TG Therapeutics Recent Developments/Updates
Table 85. Teva Company Information
Table 86. Teva Description and Business Overview
Table 87. Teva CD20 Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Teva CD20 Monoclonal Antibodies Product
Table 89. Teva Recent Developments/Updates
Table 90. Biogen Company Information
Table 91. Biogen Description and Business Overview
Table 92. Biogen CD20 Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Biogen CD20 Monoclonal Antibodies Product
Table 94. Biogen Recent Developments/Updates
Table 95. Amgen Company Information
Table 96. Amgen Description and Business Overview
Table 97. Amgen CD20 Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Amgen CD20 Monoclonal Antibodies Product
Table 99. Amgen Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer CD20 Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Pfizer CD20 Monoclonal Antibodies Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Celltrion Company Information
Table 106. Celltrion Description and Business Overview
Table 107. Celltrion CD20 Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Celltrion CD20 Monoclonal Antibodies Product
Table 109. Celltrion Recent Developments/Updates
Table 110. Shanghai Henlius Biotec Company Information
Table 111. Shanghai Henlius Biotec Description and Business Overview
Table 112. Shanghai Henlius Biotec CD20 Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Shanghai Henlius Biotec CD20 Monoclonal Antibodies Product
Table 114. Shanghai Henlius Biotec Recent Developments/Updates
Table 115. Innovent Biologics Company Information
Table 116. Innovent Biologics Description and Business Overview
Table 117. Innovent Biologics CD20 Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Innovent Biologics CD20 Monoclonal Antibodies Product
Table 119. Innovent Biologics Recent Developments/Updates
Table 120. Shanghai Institute of Biological Products Company Information
Table 121. Shanghai Institute of Biological Products Description and Business Overview
Table 122. Shanghai Institute of Biological Products CD20 Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Shanghai Institute of Biological Products CD20 Monoclonal Antibodies Product
Table 124. Shanghai Institute of Biological Products Recent Developments/Updates
Table 125. Chia Tai-Tianqing Pharmaceutical Company Information
Table 126. Chia Tai-Tianqing Pharmaceutical Description and Business Overview
Table 127. Chia Tai-Tianqing Pharmaceutical CD20 Monoclonal Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Chia Tai-Tianqing Pharmaceutical CD20 Monoclonal Antibodies Product
Table 129. Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. CD20 Monoclonal Antibodies Distributors List
Table 133. CD20 Monoclonal Antibodies Customers List
Table 134. CD20 Monoclonal Antibodies Market Trends
Table 135. CD20 Monoclonal Antibodies Market Drivers
Table 136. CD20 Monoclonal Antibodies Market Challenges
Table 137. CD20 Monoclonal Antibodies Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of CD20 Monoclonal Antibodies
Figure 2. Global CD20 Monoclonal Antibodies Market Value by Type (US$ Million), 2021–2032
Figure 3. Global CD20 Monoclonal Antibodies Market Share by Type: 2025 & 2032
Figure 4. Chimeric Antibodies Product Picture
Figure 5. Humanized Antibodies Product Picture
Figure 6. Fully Human Antibodies Product Picture
Figure 7. Global CD20 Monoclonal Antibodies Market Value by Application (US$ Million), 2021–2032
Figure 8. Global CD20 Monoclonal Antibodies Market Share by Application: 2025 & 2032
Figure 9. Relapsing Multiple Sclerosis
Figure 10. Non-Hodgkin's lymphoma
Figure 11. Leukemia
Figure 12. Other
Figure 13. Global CD20 Monoclonal Antibodies Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global CD20 Monoclonal Antibodies Market Size (US$ Million), 2021–2032
Figure 15. Global CD20 Monoclonal Antibodies Sales (K Units), 2021–2032
Figure 16. Global CD20 Monoclonal Antibodies Average Price (US$/Unit), 2021–2032
Figure 17. CD20 Monoclonal Antibodies Report Years Considered
Figure 18. CD20 Monoclonal Antibodies Sales Share by Manufacturers in 2025
Figure 19. Global CD20 Monoclonal Antibodies Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global CD20 Monoclonal Antibodies Players: Market Share by Revenue in CD20 Monoclonal Antibodies in 2025
Figure 21. CD20 Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global CD20 Monoclonal Antibodies Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America CD20 Monoclonal Antibodies Sales Market Share by Country (2021–2032)
Figure 24. North America CD20 Monoclonal Antibodies Revenue Market Share by Country (2021–2032)
Figure 25. United States CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe CD20 Monoclonal Antibodies Sales Market Share by Country (2021–2032)
Figure 28. Europe CD20 Monoclonal Antibodies Revenue Market Share by Country (2021–2032)
Figure 29. Germany CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific CD20 Monoclonal Antibodies Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific CD20 Monoclonal Antibodies Revenue Market Share by Region (2021–2032)
Figure 36. China CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America CD20 Monoclonal Antibodies Sales Market Share by Country (2021–2032)
Figure 44. Latin America CD20 Monoclonal Antibodies Revenue Market Share by Country (2021–2032)
Figure 45. Mexico CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa CD20 Monoclonal Antibodies Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa CD20 Monoclonal Antibodies Revenue Market Share by Country (2021–2032)
Figure 51. Turkey CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE CD20 Monoclonal Antibodies Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of CD20 Monoclonal Antibodies by Type (2021–2032)
Figure 55. Global Revenue Market Share of CD20 Monoclonal Antibodies by Type (2021–2032)
Figure 56. Global CD20 Monoclonal Antibodies Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of CD20 Monoclonal Antibodies by Application (2021–2032)
Figure 58. Global Revenue Market Share of CD20 Monoclonal Antibodies by Application (2021–2032)
Figure 59. Global CD20 Monoclonal Antibodies Price (US$/Unit) by Application (2021–2032)
Figure 60. CD20 Monoclonal Antibodies Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
